Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading - Top-Institutions - MDSpire

Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading

  • By

  • J. E. Freund

  • E. I. M. L. Liem

  • C. D. Savci-Heijink

  • J. Baard

  • G. M. Kamphuis

  • J. J. M. C. H. de la Rosette

  • D. M. de Bruin

  • January 25, 2019

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Radboud University Medical Center
    Radboud University Medical Center

    Nijmegen, Netherlands

    Key Differentiators

    • Urologic Oncology
    • Endourology
    • Translational Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urologic Oncology
    • Endourology
    • Cancer Imaging

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urologic Oncology
    • Endourology
    • Pathology

  • #4

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Urologic Oncology
    • Cancer Imaging
    • Translational Research

Original Source(s)

Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading

  • by J. E. Freund, E. I. M. L. Liem, C. D. Savci-Heijink, J. Baard, G. M. Kamphuis, J. J. M. C. H. de la Rosette, D. M. de Bruin

  • January 25, 2019

Related Content

T2 mapping for the characterization of prostate lesions

Early experience with targeted and combination biopsies in prostate cancer work-up in Denmark from 2012 to 2016

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study